The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK.
Irma J A de BruinCaroline E WyersPatrick C SouvereinTjeerd Pieter van StaaPiet P M M GeusensJoop P W van den BerghFrank de VriesAnnemariek H M DriessenPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2020)
The risk of a subsequent major non-hip fragility fractures following hip fracture was not increased in patients with CKD G3-G5 compared to eGFR > 60 ml/min. Mortality risk was higher in both hip fracture and non-hip fracture patients with CKD G4 and G5. The higher mortality risk may, as competing risk, explain our main finding of no increased or even decreased subsequent fracture risk after a hip fracture in patients with CKD G3-G5.